Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients

Eur J Med Genet. 2015 Dec;58(12):654-8. doi: 10.1016/j.ejmg.2015.11.002. Epub 2015 Nov 6.

Abstract

Spinal Muscular Atrophy (SMA) is a neurodegenerative disease with autosomal recessive inheritance. Homozygous loss of exon 7 of the Survival of motor neuron 1 (SMN1) gene is the main cause of SMA. Although progressive muscle weakness and atrophy are common symptoms, disease severity varies from severe to mild. Type III is one of the milder and less frequent forms of SMA. In this study, we report molecular genetic characteristics of 24 Turkish type III SMA patients. Homozygous loss of SMN1 exon 7 and 8 was analysed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and multiplex ligation dependent probe amplification (MLPA). SMN2, homologue of SMN1, and Neuronal apoptosis inhibitory protein (NAIP) genes were also evaluated considering their influence on disease severity. We determined that male patients who were born in consanguineous families were predominant in our cohort and these patients mostly carry the homozygous loss of SMN1 exon 7 and 8 and four copies of SMN2 gene without NAIP deletions.

Keywords: NAIP gene; SMN1 gene; SMN2 gene copy number; Spinal muscular atrophy type III.

MeSH terms

  • Adult
  • Consanguinity
  • DNA Copy Number Variations*
  • Exons
  • Female
  • Gene Deletion*
  • Homozygote
  • Humans
  • Male
  • Neuronal Apoptosis-Inhibitory Protein / genetics*
  • Spinal Muscular Atrophies of Childhood / diagnosis*
  • Spinal Muscular Atrophies of Childhood / genetics*
  • Survival of Motor Neuron 1 Protein / genetics*
  • Survival of Motor Neuron 2 Protein / genetics*
  • Turkey
  • Young Adult

Substances

  • Neuronal Apoptosis-Inhibitory Protein
  • Survival of Motor Neuron 1 Protein
  • Survival of Motor Neuron 2 Protein